Wells Fargo Initiates Coverage On Helus Pharma with Overweight Rating, Announces Price Target of $16

Benzinga · 3d ago
Wells Fargo analyst Benjamin Burnett initiates coverage on Helus Pharma (NASDAQ:HELP) with a Overweight rating and announces Price Target of $16.